Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Peter Marks
Pharma
FDA revisits CAR-T boxed warning on secondary cancers: Marks
“We are in the process ... of reevaluating the need for the current labeling on these products,” Peter Marks, M.D., Ph.D., said of the warnings.
Angus Liu
Nov 1, 2024 10:30am
FDA's Peter Marks talks gene therapy pricing, patient follow-ups
May 8, 2024 10:55am
FDA's Peter Marks shares more on CAR-T secondary cancer probe
Jan 25, 2024 10:42am
FDA's Marks went against reviewers' call on Sarepta's Elevidys
Jun 26, 2023 11:35am
FDA advisors vote to standardize COVID vaccines as bivalent
Jan 27, 2023 10:51am
FDA ups nod for GSK's Boostrix to protect babies from pertussis
Oct 10, 2022 10:08am
